Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 1, 2012, Pages 139-151

  Das, Surajit ^a   Ng, Wai Kiong ^a   Tan, Reginald B H ^a,b  

^a INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Characterization; Clotrimazole; Drug release; Nanostructured lipid carrier; Solid lipid nanoparticle; Stability

Indexed keywords

CLOTRIMAZOLE; DRUG CARRIER; NANOSTRUCTURED LIPID CARRIER; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CLOTRIMAZOLE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG STABILITY; LIPIDS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NANOSTRUCTURES; PARTICLE SIZE; X-RAY DIFFRACTION;

EID: 84864243269     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.05.010     Document Type: Article

References (35)

1. A.J. Almeida, and E. Souto Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv. Drug Deliv. Rev. 59 2007 478 490
2. + channel by clotrimazole Ann. N. Y. Acad. Sci. 763 1995 262 271
3. C.C. Chen, T.H. Tsai, Z.R. Huang, and J.Y. Fang Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics Eur. J. Pharm. Biopharm. 74 2010 474 482
4. S. Das, and A. Chaudhury Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery AAPS PharmSciTech 12 2011 62 76
5. S. Das, W.K. Ng, P. Kanaujia, S. Kim, and R.B.H. Tan Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables Colloids Surf. B: Biointerfaces 88 2011 483 489
6. S. Das, W.K. Ng, and R.B.H. Tan Development and in vitro evaluations of a lipid nanoparticle formulation containing tretinoin G. Tiddy, R.B.H. Tan, NanoFormulation 2012 RSC Publishing London 38 52
7. C. Freitas, and R.H. Müller Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN®) dispersions Int. J. Pharm. 168 1998 221 229
8. )) and crystallinity of the lipid phase Eur. J. Pharm. Biopharm. 47 1999 125 132
9. P. Gershkovich, and A. Hoffman Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lipoproteins Eur. J. Pharm. Sci. 32 2007 24 32
10. A. Hanafy, H. Spahn-Langguth, G. Vergnault, P. Grenier, M. Tubic Grozdanis, T. Lenhardt, and P. Langguth Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug Adv. Drug Deliv. Rev. 59 2007 419 426
11. L. Hu, X. Tang, and F. Cui Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs J. Pharm. Pharmacol. 56 2004 1527 1535
12. C.E. Kast, C. Valenta, M. Leopold, and A. Bernkop-Schnurch Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole J. Control. Release 81 2002 347 354
13. A. Kovacevic, S. Savic, G. Vuleta, R.H. Muller, and C.M. Keck Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure Int. J. Pharm. 406 2011 163 172
14. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery Int. J. Pharm. 328 2007 191 195
15. M. Muchow, P. Maincent, and R.H. Muller Lipid nanoparticles with a solid matrix (SLN®, NLC®, LDC®) for oral drug delivery Drug Dev. Ind. Pharm. 34 2008 1394 1405
16. R.H. Müller, S. Maassen, H. Weyhers, and W. Mehnert Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407 J. Drug Targeting 4 1996 161 170
17. R.H. Müller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
18. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
19. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 2002 S131 S155
20. R.H. Müller, R.D. Petersen, A. Hommoss, and J. Pardeike Nanostructured lipid carriers (NLC) in cosmetic dermal products Adv. Drug Deliv. Rev. 59 2007 522 530
21. J. Pardeike, A. Hommoss, and R.H. Müller Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Int. J. Pharm. 366 2009 170 184
22. C.W. Pouton Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 29 2006 278 287
23. B. Prabagar, B.K. Yoo, J.S. Woo, J.A. Kim, J.D. Rhee, M.G. Piao, H.G. Choi, and C.S. Yong Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin Arch. Pharm. Res. 30 2007 249 254
24. M. Radtke, E.B. Souto, and R.H. Müller Nanostructured lipid carriers: a novel generation of solid lipid drug carriers Pharm. Technol. Eur. 17 2005 45 50
25. A. Saupe, K.C. Gordon, and T. Rades Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy Int. J. Pharm. 314 2006 56 62
26. M. Schafer-Korting, W. Mehnert, and H.C. Korting Lipid nanoparticles for improved topical application of drugs for skin diseases Adv. Drug Deliv. Rev. 59 2007 427 443
27. E.B. Souto, and R.H. Müller Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams Pharmazie 62 2007 505 509
28. L.G. Souza, E.J. Silva, A.L. Martins, M.F. Mota, R.C. Braga, E.M. Lima, M.C. Valadares, S.F. Taveira, and R.N. Marreto Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release Eur. J. Pharm. Biopharm. 79 2011 189 196
29. R. Tiwari, and K. Pathak Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake Int. J. Pharm. 415 2011 232 243
30. J. Varshosaz, M. Minayian, and E. Moazen Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles J. Liposome Res. 20 2010 115 123
31. J.A. Vazquez Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients HIV Clin. Trials 1 2000 47 59
32. K. Westesen, H. Bunjes, and M.H.J. Koch Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential J. Control. Release 48 1997 223 236
33. S.A. Wissing, O. Kayser, and R.H. Muller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272
34. H.L. Wong, R. Bendayan, A.M. Rauth, Y. Li, and X.Y. Wu Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 491 504
35. C.S. Yong, D.X. Li, B. Prabagar, B.C. Park, S.J. Yi, B.K. Yoo, W.S. Lyoo, J.S. Woo, J.D. Rhee, J.A. Kim, and H.G. Choi The effect of beta-cyclodextrin complexation on the bioavailability and hepatotoxicity of clotrimazole Pharmazie 62 2007 756 759